Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

[1]  S. Capellari,et al.  Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  A. Karch,et al.  A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  L. Schonberger,et al.  Diagnosis of prion diseases by RT-QuIC results in improved surveillance , 2020, Neurology.

[4]  A. Bizzi,et al.  Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease , 2020, Acta Neuropathologica.

[5]  L. Sacchetto,et al.  Transmission of CJD from nasal brushings but not spinal fluid or RT‐QuIC product , 2020, Annals of clinical and translational neurology.

[6]  A. Bizzi,et al.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging. , 2020, JAMA neurology.

[7]  E. Lander,et al.  Towards a treatment for genetic prion disease: trials and biomarkers , 2020, The Lancet Neurology.

[8]  P. Liberski,et al.  Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases , 2020, Neuropathology and Applied Neurobiology.

[9]  B. Caughey,et al.  Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients , 2020, Annals of clinical and translational neurology.

[10]  L. Sacchetto,et al.  High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD , 2020, International journal of molecular sciences.

[11]  Victoria J. Williams,et al.  Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease , 2019, BMC Medicine.

[12]  S. Carr,et al.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry. , 2019, Molecular & cellular proteomics : MCP.

[13]  K. Blennow,et al.  Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias , 2019, Alzheimer's & Dementia.

[14]  A. Green,et al.  Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC , 2019, Journal of Neurology.

[15]  S. Lehmann,et al.  Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[16]  K. Blennow,et al.  Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease. , 2019, JAMA neurology.

[17]  S. Schreiber,et al.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development , 2019, Proceedings of the National Academy of Sciences.

[18]  C. Soto,et al.  PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study , 2019, Scientific Reports.

[19]  I. Ferrer,et al.  Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease , 2019, Journal of Clinical Neuroscience.

[20]  B. Caughey,et al.  Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients , 2018, mBio.

[21]  S. Sorbi,et al.  Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges , 2018, Annals of neurology.

[22]  A. Karch,et al.  Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases , 2018, Molecular Neurobiology.

[23]  K. Blennow,et al.  Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease , 2018, Alzheimer's & dementia.

[24]  K. Blennow,et al.  Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod , 2018, Multiple sclerosis.

[25]  W. Schulz-Schaeffer,et al.  Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance , 2018, Neurology.

[26]  K. Blennow,et al.  Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases , 2018, Alzheimer's & Dementia.

[27]  C. Masters,et al.  CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt–Jakob disease diagnosis while transitioning to next generation diagnostics , 2018, Journal of Clinical Neuroscience.

[28]  S. Mead,et al.  Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  A. Green,et al.  Rapid amplification of prions from variant Creutzfeldt–Jakob disease cerebrospinal fluid , 2018, The journal of pathology. Clinical research.

[30]  P. Martinelli,et al.  The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias , 2018, Alzheimer's Research & Therapy.

[31]  B. Steinhoff,et al.  Periodic EEG patterns in sporadic Creutzfeld-Jakob-Disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus , 2017, Seizure.

[32]  B. Caughey,et al.  Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease , 2017, Science Translational Medicine.

[33]  J. Collinge,et al.  Imaging and CSF analyses effectively distinguish CJD from its mimics , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[34]  E. Thouvenot,et al.  FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation , 2017, Prion.

[35]  C. Duyckaerts,et al.  Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  G. Belay,et al.  Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review , 2017, Molecular Neurobiology.

[37]  B. Caughey,et al.  High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions , 2017, Scientific Reports.

[38]  K. Blennow,et al.  Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology‐based cohort , 2017, European journal of neurology.

[39]  T. Asano,et al.  An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay , 2017, Prion.

[40]  B. Mollenhauer,et al.  Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases , 2017, Alzheimer's & Dementia.

[41]  O. Kim,et al.  Redefining periodic patterns on electroencephalograms of patients with sporadic Creutzfeldt–Jakob disease , 2017, Clinical Neurophysiology.

[42]  A. Karch,et al.  Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease , 2017, Molecular Neurobiology.

[43]  A. Green,et al.  Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels , 2017, Acta Neuropathologica.

[44]  L. Sacchetto,et al.  Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples , 2017, JAMA neurology.

[45]  A. Karch,et al.  Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs , 2017, Dementia and Geriatric Cognitive Disorders.

[46]  B. Caughey,et al.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid , 2017, Annals of neurology.

[47]  B. Caughey,et al.  Extended and direct evaluation of RT‐QuIC assays for Creutzfeldt‐Jakob disease diagnosis , 2016, Annals of clinical and translational neurology.

[48]  J. Laplanche,et al.  Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease , 2016, Science Translational Medicine.

[49]  C. Soto,et al.  Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease , 2016, Science Translational Medicine.

[50]  K. Blennow,et al.  Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease , 2016, Scientific Reports.

[51]  Nick C Fox,et al.  Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. , 2016, JAMA neurology.

[52]  S. Capellari,et al.  Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer’s Disease with Emphasis on Atypical Disease Variants , 2016, Journal of Alzheimer's disease : JAD.

[53]  A. Karch,et al.  Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia. , 2016, Journal of Alzheimer's disease : JAD.

[54]  B. Caughey,et al.  The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases , 2016, Nature Protocols.

[55]  A. Karch,et al.  Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard. , 2016, Journal of clinical epidemiology.

[56]  A. Cagnin,et al.  Long‐term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt–Jakob disease , 2016, Annals of neurology.

[57]  Jessica Lowe,et al.  Quantitative EEG parameters correlate with the progression of human prion diseases , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[58]  B. Caughey,et al.  Advanced tests for early and accurate diagnosis of Creutzfeldt–Jakob disease , 2016, Nature Reviews Neurology.

[59]  P. Cras,et al.  Cerebrospinal fluid real‐time quaking‐induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study , 2016, Annals of neurology.

[60]  I. Santana,et al.  Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay , 2016, Neuroscience.

[61]  A. Karch,et al.  Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia , 2016, Alzheimer's & Dementia.

[62]  A. Karch,et al.  Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic , 2016, Molecular Neurobiology.

[63]  Young Ho Park,et al.  The Clinical Stages of Sporadic Creutzfeldt-Jakob Disease with Met/Met Genotype in Korean Patients , 2016, European Neurology.

[64]  J. Chapman,et al.  CSF tau correlates with CJD disease severity and cognitive decline , 2016, Acta neurologica Scandinavica.

[65]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[66]  Yong-Sun Kim,et al.  Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea , 2015, Journal of clinical neurology.

[67]  B. Ghetti,et al.  Bank Vole Prion Protein As an Apparently Universal Substrate for RT-QuIC-Based Detection and Discrimination of Prion Strains , 2015, PLoS pathogens.

[68]  A. Karch,et al.  Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease , 2015, Neurobiology of Aging.

[69]  Ming Yang,et al.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt–Jakob disease , 2015, Journal of Neurology.

[70]  J. Neuhaus,et al.  Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease , 2015, Neurology. Clinical practice.

[71]  A. Karch,et al.  Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease , 2015, Molecular Neurobiology.

[72]  A. Vighetto,et al.  Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. , 2015, JAMA neurology.

[73]  B. Caughey,et al.  Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid , 2015, mBio.

[74]  R. Henry,et al.  White matter involvement in sporadic Creutzfeldt-Jakob disease , 2014, Brain : a journal of neurology.

[75]  B. Caughey,et al.  A test for Creutzfeldt-Jakob disease using nasal brushings. , 2014, The New England journal of medicine.

[76]  C. Soto,et al.  Prions in the urine of patients with variant Creutzfeldt-Jakob disease. , 2014, The New England journal of medicine.

[77]  K. Blennow,et al.  Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. , 2014, JAMA neurology.

[78]  J. Stevens,et al.  MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease , 2012, BMC Neurology.

[79]  Taim A. Muayqil,et al.  Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease , 2012 .

[80]  A. Aguzzi,et al.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years , 2012, Brain : a journal of neurology.

[81]  A. Bizzi,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.

[82]  Mary Andrews,et al.  Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease , 2012, Annals of neurology.

[83]  G. Jansen,et al.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study , 2011, BMC neurology.

[84]  R. Henry,et al.  Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias , 2011, Neurology.

[85]  M. Noguchi-Shinohara,et al.  Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease , 2011, Journal of Neurology.

[86]  Steven J Collins,et al.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.

[87]  Brent Race,et al.  Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.

[88]  A. Green,et al.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[89]  M. Baulac,et al.  Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus , 2010, Neurology.

[90]  J. Ironside,et al.  Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease , 2010, Annals of Neurology.

[91]  E. Karageorgiou,et al.  Neuroimaging in Dementia , 2017, Seminars in Neurology.

[92]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[93]  B. Caughey,et al.  Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein , 2007, Nature Methods.

[94]  J Mackenzie,et al.  Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. , 2006, Brain : a journal of neurology.

[95]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[96]  A. Petzold.  Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss , 2005, Journal of the Neurological Sciences.

[97]  A. Aguzzi,et al.  Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada , 2005, Neurology.

[98]  B. Steinhoff,et al.  Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease , 2004, Annals of neurology.

[99]  D. Berg,et al.  14-3-3 proteins in the nervous system , 2003, Nature Reviews Neuroscience.

[100]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[101]  H. Vanderstichele,et al.  Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias , 2003, Molecular Psychiatry.

[102]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[103]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[104]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[105]  K. Jellinger,et al.  Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.

[106]  D. Altman,et al.  Statistics Notes: Diagnostic tests 2: predictive values , 1994, BMJ.

[107]  G. Kovacs,et al.  Genetic Creutzfeldt-Jakob disease. , 2018, Handbook of clinical neurology.

[108]  Sebastian Brandner,et al.  Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation. , 2016, JAMA neurology.